Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

Annals of Hematology

Volumn 88, Issue 10, 2009, Pages 1005-1013

  Giebel, Sebastian ^a   Labopin, Myriam ^b   Holowiecki, Jerzy ^a   Labar, Boris ^c   Komarnicki, Mieczyslaw ^d   Koza, Vladimir ^e   Masszi, Tamas ^f   Mistrik, Martin ^g   Lange, Andrzej ^h   Hellmann, Andrzej ⁱ   Vitek, Antonin ^j   Pretnar, Joze ^k   Mayer, Jiri ^l   Rzepecki, Piotr ^m   Indrak, Karel ⁿ   Wiktor Jedrzejczak, Wieslaw ^o   Wojnar, Jerzy ^p   Krawczyk Kulis, Malgorzata ^p   Kyrcz Krzemien, Slawomira ^p   Rocha, Vanderson ^q  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b HÔPITAL SAINT ANTOINE   (France)

^c KBC Zagreb   (Croatia)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e CHARLES UNIVERSITY   (Czech Republic)

^f Szent Laszlo Hospital   (Hungary)

^g University of Brastislava   (Slovakia)

^h Lower Silesian Center for Cellular Transplantation with National Bone Marrow Donor Registry   (Poland)

ⁱ MEDICAL UNIVERSITY OF GDANSK   (Poland)

^j INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^k UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^l UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^m MILITARY INSTITUTE OF MEDICINE   (Poland)

ⁿ UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^o MEDICAL UNIVERSITY OF WARSAW   (Poland)

^p MEDICAL UNIVERSITY OF SILESIA   (Poland)

^q SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

Acute leukemia; Leukemia free survival; Matched related donor HSCT; Nonrelapse mortality; Prognostic factors

Indexed keywords

BUSULFAN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EASTERN EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; EUROPE, EASTERN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 69249235616     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0719-5     Document Type: Article

References (29)

1. Thomas X, Boiron JM, Huguet F et al (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trial. J Clin Oncol 22:4075-4086. doi: 10.1200/JCO.2004.10.050
2. Labar B, Suciu S, Zittoun R et al (2004) Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or = 50 years old in first complete remission: Results of the EORTC ALL-3 trial. Haematologica 89:809-817
3. Goldstone AH, Richards SM, Lazarus HM et al (2007) In adults with standard-risk acute lymphoblastic leukemia (ALL) the greatest benefit is achieved from a matched sibling allogeneic transplant in first complete remission (CR) and an autologous transplant is less effective than conventional consolidation/maintenance chemotherapy in All patients: final results of the international ALL trial (MRC UKALL XII/ECOG E2993). Blood 111:1827-1833. doi: 10.1182/blood-2007-10-116582
4. Zittoun RA, Mandelli F, Willemze R et al (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 332:217-223. doi: 10.1056/NEJM199501263320403
5. Gale RP, Büchner T, Zhang MJ et al (1996) HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. Leukemia 10:1687-1691
6. Cassileth PA, Harrington DP, Appelbaum FR et al (1998) Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 339:1649-1656. doi: 10.1056/NEJM199812033392301
7. Reiffers J, Stoppa AM, Attal M et al (1996) Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: The BGMT 87 study. Leukemia 10:1874-1882
8. Burnett AK, Wheatley K, Goldstone AH et al (2002) The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: Results of the UK MRC AML 10 trial. Br J Haematol 118:385-400. doi: 10.1046/j.1365-2141.2002.03724.x
9. Cornelissen JJ, van Putten WL, Verdonck LF et al (2007) Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: Benefits for whom? Blood 109:3658-3666. doi: 10.1182/blood-2006-06-025627
10. Gratwohl A, Baldomero H, Frauendorfer K et al (2008) The EBMT activity survey 2006 on hematopoietic stem cell transplantation: Focus on the use of cord blood products. Bone Marrow Transplant 41:687-705. doi: 10.1038/ sj.bmt.1705956
11. Gratwohl A, Baldomero H, Schwendener A et al (2007) Predictability of hematopoietic stem cell transplantation rates. Haematologica 92:1679-1686. doi: 10.3324/haematol.11260
12. Gratwohl A, Baldomero H, Labar B et al (2004) Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity survey. Croat Med J 45:689-694
13. Frassoni F, Labopin M, Powles R et al (2000) Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 355:1393-1398. doi: 10.1016/S0140-6736(00)02137-1
14. Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 18:695-706. doi: 10.1002/ (SICI) 1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O
15. Fine JP, Gray RJ (1999) A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc 94:496-509. doi: 10.2307/2670170
16. Ringdén O, Labopin M, Bacigalupo A et al (2002) Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 20:4655-4664. doi: 10.1200/ JCO.2002.12.049
17. Champlin RE, Schmitz N, Horowitz MM et al (2000) Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 95:3702-3709
18. Powles R, Mehta J, Kulkarni S et al (2000) Allogeneic blood and bone marrow stem-cell transplantation in haematological malignant diseases: A randomized trial. Lancet 355:1231-1237. doi: 10.1016/ S0140-6736(00)02090-0
19. Blaise D, Kuentz M, Fortanier C et al (2000) Randomized trial of bone marrow versus lenograstimprimed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Franciase de Greffe de Molle. J Clin Oncol 18:537-546
20. Bensinger WI, Martin PJ, Storer B et al (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344:175-181. doi: 10.1056/NEJM200101183440303
21. Schmitz N, Beksac M, Hasenclever D et al (2002) Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard risk leukemia. Blood 100:761-767. doi: 10.1182/blood-2001-12-0304
22. Couban S, Simpson DR, Barnett MJ et al (2002) A randomized multi-center comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 100:1525-1531. doi: 10.1182/blood-2002-01-0048
23. Schmitz N, Eapen M, Horowitz MM et al (2006) Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 108:4288-4290. doi: 10.1182/blood-2006-05-024042
24. Stem Cell Trialists' Collaborative Group (2005) Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials. J Clin Oncol 23:5074-5087. doi: 10.1200/JCO.2005.09.020
25. Hahn T, Wall D, Camitta B et al (2006) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: An evidence-based review. Biol Blood Marrow Transplant 12:1-30. doi: 10.1016/j.bbmt.2005.10.018
26. Hahn T, Wall D, Camitta B et al (1992) Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of a busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: A report from the Groupe d'Etudes de la Greffe de Moelle Osseuse. Blood 79:2578-2582
27. Ringden O, Ruutu T, Remberger M et al (1994) A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemiaa report from the Nordic Bone Marrow Transplantation Group. Blood 83:2723-2730
28. Litzow MR, Pérez WS, Klein JP (2002) Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. Br J Haematol 119:1115-1124. doi: 10.1046/ j.1365-2141.2002.03973.x
29. Socié G, Clift RA, Blaise D et al (2001) Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 98:3569-3574. doi: 10.1182/blood.V98.13.3569